Beam Therapeutics Inc.
MX ˙ BMV ˙ US07373V1052
SecurityMX:BEAM / Beam Therapeutics Inc.
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership31,099 shares
Latest Disclosed Value $ 741,089
Victory Capital Management Inc reports 0.38% increase in ownership of BEAM / Beam Therapeutics Inc.

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 31,099 shares of Beam Therapeutics Inc. (MX:BEAM) valued at $741,089 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 30,982 shares of Beam Therapeutics Inc.. This represents a change in shares of 0.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BEAM THERAPEUTICS COM 07373V105 31,099 117 0.38 741 -13.64 0.0004
2026-02-13 2025-12-31 13F BEAM THERAPEUTICS COM 07373V105 30,982 106 0.34 859 14.55 0.0005
2025-11-12 2025-09-30 13F BEAM THERAPEUTICS COM 07373V105 30,876 -167 -0.54 749 41.86 0.0004
2025-08-13 2025-06-30 13F BEAM THERAPEUTICS COM 07373V105 31,043 20,431 192.53 528 155.07 0.0003
2025-05-02 2025-03-31 13F BEAM THERAPEUTICS COM 07373V105 10,612 1,618 17.99 207 -7.17 0.0002
2025-02-06 2024-12-31 13F BEAM THERAPEUTICS COM 07373V105 8,994 -99 -1.09 223 0.45 0.0002
2024-11-05 2024-09-30 13F BEAM THERAPEUTICS COM 07373V105 9,093 -828 -8.35 223 -4.31 0.0002
2024-08-05 2024-06-30 13F BEAM THERAPEUTICS COM 07373V105 9,921 973 10.87 232 -21.36 0.0002
2024-05-03 2024-03-31 13F BEAM THERAPEUTICS COM 07373V105 8,948 -334 -3.60 296 17.06 0.0003
2024-02-05 2023-12-31 13F BEAM THERAPEUTICS COM 07373V105 9,282 9,282 253 0.0003
2023-11-06 2023-09-30 13F BEAM THERAPEUTICS COM 07373V105 0 -21,483 -100.00 0 -100.00
2023-07-27 2023-06-30 13F BEAM THERAPEUTICS COM 07373V105 21,483 -151 -0.70 686 3.47 0.0008
2023-05-02 2023-03-31 13F BEAM THERAPEUTICS COM 07373V105 21,634 1,677 8.40 662 -15.13 0.0007
2023-04-25 2022-12-31 13F/A-3 BEAM THERAPEUTICS COM 07373V105 19,957 -1,236 -5.83 781 -22.77 0.0009
2023-03-10 2022-12-31 13F/A-2 BEAM THERAPEUTICS COM 07373V105 19,957 -1,236 781 0.0005
2023-02-10 2022-12-31 13F/A-1 BEAM THERAPEUTICS COM 07373V105 19,957 -1,236 781 0.0005
2023-02-09 2022-12-31 13F BEAM THERAPEUTICS COM 07373V105 19,900 -1,293 865 0.0006
2022-11-02 2022-09-30 13F BEAM THERAPEUTICS COM 07373V105 21,193 -384 -1.78 1,010 20.96 0.0012
2022-08-01 2022-06-30 13F BEAM THERAPEUTICS COM 07373V105 21,577 -663,609 -96.85 835 -97.85 0.0010
2022-05-04 2022-03-31 13F BEAM THERAPEUTICS COM 07373V105 685,186 107,516 18.61 38,776 -15.77 0.0388
2022-02-07 2021-12-31 13F BEAM THERAPEUTICS COM 07373V105 577,670 -120,209 -17.22 46,035 -24.19 0.0424
2021-11-02 2021-09-30 13F BEAM THERAPEUTICS COM 07373V105 697,879 163,750 30.66 60,723 -11.67 0.0595
2021-08-03 2021-06-30 13F BEAM THERAPEUTICS COM 07373V105 534,129 -59,476 -10.02 68,747 44.69 0.0660
2021-05-04 2021-03-31 13F BEAM THERAPEUTICS COM 07373V105 593,605 515,886 663.78 47,513 648.83 0.0487
2021-02-01 2020-12-31 13F BEAM THERAPEUTICS COM 07373V105 77,719 -22,022 -22.08 6,345 158.35 0.0071
2020-11-09 2020-09-30 13F Beam Therapeutics COM 07373V105 99,741 -18,437 -15.60 2,456 -25.78 0.0032
2020-08-07 2020-06-30 13F BEAM THERAPEUTICS COM 07373V105 118,178 -146,693 -55.38 3,309 -30.60 0.0045
2020-05-12 2020-03-31 13F/A-1 BEAM THERAPEUTICS COM 07373V105 264,871 264,871 4,768 0.0080
2020-05-04 2020-03-31 13F BEAM THERAPEUTICS COM 07373V105 264,871 4,768
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.